Evidence map›Paper›PMID 36224196›Full record

ArticleScientific reports2022

Increased genetic variation of A(H3N2) virus from influenza surveillance at the end of the 2016/2017 season for Shanghai port, China.

Zilong Zhang, Shenwei Li, Xiaolin Zhu, Jian Hou, Hong Zhang, Baihui Zhao, Zhengan Tian

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zilong Zhang *Shanghai International Travel Healthcare Center, Shanghai, 200335, China.
Shenwei Li *Shanghai International Travel Healthcare Center, Shanghai, 200335, China.
Xiaolin Zhu *Shanghai BioGerm Medical Biotechnology Co., Ltd, Shanghai, 201401, China.
Jian HouShanghai Customs District P.R.China, Shanghai, 200135, China.
Hong ZhangShanghai International Travel Healthcare Center, Shanghai, 200335, China.
Baihui ZhaoBio-X Life Science Research Center, Shanghai Jiao Tong University, Shanghai, 200030, China.
Zhengan TianShanghai International Travel Healthcare Center, Shanghai, 200335, China. tianzhenganciq@163.com.
Shanghai Customs College · CNShenzhen International Travel Health Care Center · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A(H3N2) virus exhibited complex seasonal patterns to evade pre-existing antibodies, resulting in changes in the antigenicity of the viron surface protein hemagglutinin (HA). To monitor the currently imported influenza viruses as well as to assess the capacity of health emergencies at the Shanghai port, we collected respiratory specimens of passengers from different countries and regions including some of Europe with influenza-like illness at the Shanghai port during 2016/2017, examined amino acid substitutions, and calculated the perfect-match vaccine efficacy using the p epitope model. Phylogenetic analysis of the HA genes revealed that influenza A(H3N2) viruses belonging to eight subclades were detected, and three amino acid substitutions in the subclade 3C.2a.4 were also added. Besides, two epidemic influenza virus strains were found in the 2016/2017 winter and 2016 summer. The results of lower predicted vaccine effectiveness in summer suggest that the imported A(H3N2) strains were not a good match for the A/Hong Kong/4801/2014 vaccine strain since the summer of 2017. Therefore, the Shanghai Port might stop the risk of the international spread of influenza for the first time, and curb the entry of A(H3N2) from overseas at the earliest stage of a probable influenza pandemic.

Indexed as

Influenza A virusInfluenza, HumanInfluenza VaccinesChinaEpitopesGenetic VariationHemagglutinin Glycoproteins, Influenza VirusHemagglutininsHumansInfluenza A Virus, H3N2 SubtypeMembrane ProteinsPhylogenySeasonsEpitopesHemagglutinin Glycoproteins, Influenza VirusHemagglutininsInfluenza VaccinesMembrane Proteins

Identifiers

PMID36224196
PMCPMC9556717
OpenAlexW4304692375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.